Skip to main content
. Author manuscript; available in PMC: 2018 Dec 20.
Published in final edited form as: Curr Med Chem. 2018;25(34):4208–4223. doi: 10.2174/0929867324666170920160030

Figure 2. Scheme of theranostic agents.

Figure 2

Multilayer theranostic agents are usually constituted by a core with imaging and therapeutic properties and a coating that increase loading capability of the therapeutic payload and can provide also targeting for cancer lesions. Usually the core is represented by metallic particles with NIR or contrast properties enable upon external treatment of generating heat that can favor, cancer cells killing and release of the therapeutic payload.